Search This Blog

Wednesday, July 24, 2019

Anika Therapeutics EPS beats by $0.27, beats on revenue

Anika Therapeutics (NASDAQ:ANIK): Q2 GAAP EPS of $0.67 beats by $0.27.
Revenue of $30.42M (-0.4% Y/Y) beats by $3.01M.
Shares -0.07%.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)